

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to ATP (GO:0071318) | 9.81540173 |
| 2 | negative regulation of cell aging (GO:0090344) | 9.75707387 |
| 3 | DNA strand renaturation (GO:0000733) | 9.25793435 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 8.77273000 |
| 5 | adenosine receptor signaling pathway (GO:0001973) | 7.88412626 |
| 6 | meiotic chromosome segregation (GO:0045132) | 7.63056743 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.50363763 |
| 8 | protein carboxylation (GO:0018214) | 7.50363763 |
| 9 | regulation of synapse structural plasticity (GO:0051823) | 7.49968353 |
| 10 | response to muscle activity (GO:0014850) | 7.29953756 |
| 11 | visual perception (GO:0007601) | 7.08001360 |
| 12 | mitotic cell cycle arrest (GO:0071850) | 7.05980729 |
| 13 | lens morphogenesis in camera-type eye (GO:0002089) | 7.05177630 |
| 14 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 7.03341345 |
| 15 | sensory perception of light stimulus (GO:0050953) | 7.02612386 |
| 16 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 6.71029247 |
| 17 | rRNA methylation (GO:0031167) | 6.48131736 |
| 18 | regulation of protein sumoylation (GO:0033233) | 5.92428430 |
| 19 | sensory perception of taste (GO:0050909) | 5.86687407 |
| 20 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 5.85852889 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.70876337 |
| 22 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.70745134 |
| 23 | detection of light stimulus involved in visual perception (GO:0050908) | 5.70745134 |
| 24 | transepithelial transport (GO:0070633) | 5.67770603 |
| 25 | rRNA modification (GO:0000154) | 5.63472681 |
| 26 | positive regulation of protein kinase C signaling (GO:0090037) | 5.49661971 |
| 27 | purine ribonucleotide transport (GO:0015868) | 5.48447043 |
| 28 | camera-type eye development (GO:0043010) | 5.43094992 |
| 29 | adenine nucleotide transport (GO:0051503) | 5.41092377 |
| 30 | response to ATP (GO:0033198) | 5.23481241 |
| 31 | muscle cell cellular homeostasis (GO:0046716) | 5.13231825 |
| 32 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.08883702 |
| 33 | behavioral response to nicotine (GO:0035095) | 5.06910682 |
| 34 | estrogen biosynthetic process (GO:0006703) | 4.97495892 |
| 35 | granulocyte differentiation (GO:0030851) | 4.82277252 |
| 36 | protein refolding (GO:0042026) | 4.81975516 |
| 37 | purinergic receptor signaling pathway (GO:0035587) | 4.81124337 |
| 38 | urinary tract smooth muscle contraction (GO:0014848) | 4.77684466 |
| 39 | positive regulation of heat generation (GO:0031652) | 4.72403047 |
| 40 | cytolysis (GO:0019835) | 4.71654485 |
| 41 | eye development (GO:0001654) | 4.58224561 |
| 42 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.55220236 |
| 43 | nucleoside transmembrane transport (GO:1901642) | 4.53353490 |
| 44 | regulation of platelet aggregation (GO:0090330) | 4.52960811 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.49663836 |
| 46 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.43083655 |
| 47 | nucleotide transmembrane transport (GO:1901679) | 4.39408621 |
| 48 | regulation of cell aging (GO:0090342) | 4.37602938 |
| 49 | purine nucleotide transport (GO:0015865) | 4.29042610 |
| 50 | melanin biosynthetic process (GO:0042438) | 4.28568059 |
| 51 | UV protection (GO:0009650) | 4.17918300 |
| 52 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.06366943 |
| 53 | presynaptic membrane assembly (GO:0097105) | 4.05393197 |
| 54 | peristalsis (GO:0030432) | 4.03396331 |
| 55 | cellular anion homeostasis (GO:0030002) | 4.01358044 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.00724028 |
| 57 | sulfur amino acid catabolic process (GO:0000098) | 4.00627752 |
| 58 | neuromuscular synaptic transmission (GO:0007274) | 3.95613708 |
| 59 | regulation of protein kinase A signaling (GO:0010738) | 3.92075825 |
| 60 | sensory perception (GO:0007600) | 3.91024905 |
| 61 | myofibril assembly (GO:0030239) | 3.90974904 |
| 62 | sex determination (GO:0007530) | 3.86114741 |
| 63 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.85557041 |
| 64 | grooming behavior (GO:0007625) | 3.81672559 |
| 65 | melanin metabolic process (GO:0006582) | 3.81128468 |
| 66 | sphingomyelin metabolic process (GO:0006684) | 3.79005110 |
| 67 | cellular response to osmotic stress (GO:0071470) | 3.74190727 |
| 68 | phosphate ion homeostasis (GO:0055062) | 3.73873470 |
| 69 | trivalent inorganic anion homeostasis (GO:0072506) | 3.73873470 |
| 70 | cardiolipin metabolic process (GO:0032048) | 3.70814494 |
| 71 | semaphorin-plexin signaling pathway (GO:0071526) | 3.65523466 |
| 72 | sensory organ development (GO:0007423) | 3.64923175 |
| 73 | protein import into peroxisome matrix (GO:0016558) | 3.63678285 |
| 74 | histone H3-K9 demethylation (GO:0033169) | 3.62250420 |
| 75 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.60922704 |
| 76 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.60922704 |
| 77 | negative regulation of interleukin-8 production (GO:0032717) | 3.60876183 |
| 78 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.56400903 |
| 79 | folic acid metabolic process (GO:0046655) | 3.55359758 |
| 80 | iron coordination entity transport (GO:1901678) | 3.53110233 |
| 81 | regulation of heat generation (GO:0031650) | 3.50571830 |
| 82 | secondary metabolite biosynthetic process (GO:0044550) | 3.50371692 |
| 83 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.50300059 |
| 84 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.50300059 |
| 85 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.50300059 |
| 86 | presynaptic membrane organization (GO:0097090) | 3.47388149 |
| 87 | postsynaptic membrane organization (GO:0001941) | 3.46798004 |
| 88 | heme transport (GO:0015886) | 3.46081244 |
| 89 | mitochondrion distribution (GO:0048311) | 3.45918853 |
| 90 | mannose metabolic process (GO:0006013) | 3.44707051 |
| 91 | DNA replication checkpoint (GO:0000076) | 3.44524153 |
| 92 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.44022742 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.43967839 |
| 94 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 3.43095342 |
| 95 | sphingosine metabolic process (GO:0006670) | 3.42953187 |
| 96 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.40368446 |
| 97 | histone phosphorylation (GO:0016572) | 3.33692183 |
| 98 | nucleoside transport (GO:0015858) | 3.31817234 |
| 99 | protein insertion into membrane (GO:0051205) | 3.30142592 |
| 100 | peptidyl-glutamic acid modification (GO:0018200) | 3.30039505 |
| 101 | endocytic recycling (GO:0032456) | 3.28925496 |
| 102 | phosphate ion transmembrane transport (GO:0035435) | 3.28026339 |
| 103 | type B pancreatic cell proliferation (GO:0044342) | 3.25328700 |
| 104 | response to salt stress (GO:0009651) | 3.21056247 |
| 105 | diol metabolic process (GO:0034311) | 3.20121410 |
| 106 | ribosomal small subunit biogenesis (GO:0042274) | 3.18562420 |
| 107 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.17457392 |
| 108 | axon ensheathment in central nervous system (GO:0032291) | 3.17228407 |
| 109 | central nervous system myelination (GO:0022010) | 3.17228407 |
| 110 | activation of adenylate cyclase activity (GO:0007190) | 3.16655723 |
| 111 | neuron cell-cell adhesion (GO:0007158) | 3.15307344 |
| 112 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12597570 |
| 113 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 3.11621489 |
| 114 | tRNA modification (GO:0006400) | 3.11013288 |
| 115 | sialylation (GO:0097503) | 3.09709309 |
| 116 | regulation of myoblast differentiation (GO:0045661) | 3.09056306 |
| 117 | glutamate receptor signaling pathway (GO:0007215) | 3.06736020 |
| 118 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.04532024 |
| 119 | negative regulation of neurotransmitter transport (GO:0051589) | 3.01999276 |
| 120 | cerebellar granule cell differentiation (GO:0021707) | 3.00935090 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00677271 |
| 122 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.00026760 |
| 123 | lens development in camera-type eye (GO:0002088) | 26.1844601 |
| 124 | folic acid transport (GO:0015884) | 2.99675410 |
| 125 | regulation of skeletal muscle fiber development (GO:0048742) | 2.97621157 |
| 126 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.96162690 |
| 127 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.96133094 |
| 128 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.95357692 |
| 129 | forebrain neuron development (GO:0021884) | 2.94586781 |
| 130 | protein localization to synapse (GO:0035418) | 2.93914305 |
| 131 | muscle fiber development (GO:0048747) | 2.93874773 |
| 132 | gonadal mesoderm development (GO:0007506) | 2.93579611 |
| 133 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.86672183 |
| 134 | cell migration in hindbrain (GO:0021535) | 2.82562840 |
| 135 | proline biosynthetic process (GO:0006561) | 2.82458447 |
| 136 | neuronal action potential propagation (GO:0019227) | 2.82247555 |
| 137 | regulation of meiosis (GO:0040020) | 2.81954052 |
| 138 | base-excision repair, AP site formation (GO:0006285) | 2.81771886 |
| 139 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.81290819 |
| 140 | viral transcription (GO:0019083) | 2.80798114 |
| 141 | cyclic nucleotide catabolic process (GO:0009214) | 2.78927211 |
| 142 | cAMP catabolic process (GO:0006198) | 2.76875034 |
| 143 | amino acid import (GO:0043090) | 2.74099868 |
| 144 | facial nerve structural organization (GO:0021612) | 2.66927225 |
| 145 | translational termination (GO:0006415) | 2.65015303 |
| 146 | viral protein processing (GO:0019082) | 2.63596021 |
| 147 | synaptic transmission, glutamatergic (GO:0035249) | 2.63025656 |
| 148 | response to pheromone (GO:0019236) | 2.61316150 |
| 149 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 2.58351814 |
| 150 | axonal fasciculation (GO:0007413) | 2.58276717 |
| 151 | L-amino acid import (GO:0043092) | 2.58194602 |
| 152 | positive regulation of synapse assembly (GO:0051965) | 2.57529394 |
| 153 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.54863711 |
| 154 | cardiovascular system development (GO:0072358) | 2.54637820 |
| 155 | positive regulation of dendritic spine development (GO:0060999) | 2.51695678 |
| 156 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.50235703 |
| 157 | adult walking behavior (GO:0007628) | 2.49520234 |
| 158 | protein homotrimerization (GO:0070207) | 2.49490657 |
| 159 | mating behavior (GO:0007617) | 2.48723502 |
| 160 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.45557147 |
| 161 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.45500048 |
| 162 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.43807977 |
| 163 | head development (GO:0060322) | 2.42322988 |
| 164 | sarcomere organization (GO:0045214) | 2.42264773 |
| 165 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.39443698 |
| 166 | dendrite morphogenesis (GO:0048813) | 2.36993265 |
| 167 | negative regulation of platelet activation (GO:0010544) | 2.36797602 |
| 168 | negative regulation of axon guidance (GO:1902668) | 2.34264910 |
| 169 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.33929617 |
| 170 | neuron recognition (GO:0008038) | 2.33833915 |
| 171 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.33540750 |
| 172 | regulation of skeletal muscle tissue development (GO:0048641) | 2.29600944 |
| 173 | dopaminergic neuron differentiation (GO:0071542) | 2.29153297 |
| 174 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.28747747 |
| 175 | cotranslational protein targeting to membrane (GO:0006613) | 2.28162155 |
| 176 | central nervous system neuron development (GO:0021954) | 2.25011859 |
| 177 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.24948808 |
| 178 | protein targeting to ER (GO:0045047) | 2.24761812 |
| 179 | telencephalon development (GO:0021537) | 2.22493066 |
| 180 | cranial nerve structural organization (GO:0021604) | 2.21800685 |
| 181 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.21704242 |
| 182 | metanephric nephron tubule development (GO:0072234) | 2.21062502 |
| 183 | metanephric tubule development (GO:0072170) | 2.21062502 |
| 184 | regulation of axon guidance (GO:1902667) | 2.18129755 |
| 185 | neuron-neuron synaptic transmission (GO:0007270) | 2.17677786 |
| 186 | cellular response to calcium ion (GO:0071277) | 2.17080384 |
| 187 | protein localization to endoplasmic reticulum (GO:0070972) | 2.16974396 |
| 188 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.16933055 |
| 189 | astrocyte differentiation (GO:0048708) | 2.16506091 |
| 190 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.14431335 |
| 191 | neuronal stem cell maintenance (GO:0097150) | 2.14029600 |
| 192 | cellular response to pH (GO:0071467) | 2.13571056 |
| 193 | regulation of respiratory system process (GO:0044065) | 2.11841054 |
| 194 | C-terminal protein amino acid modification (GO:0018410) | 2.11724207 |
| 195 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.10585325 |
| 196 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.10580584 |
| 197 | lens fiber cell development (GO:0070307) | 18.3263335 |
| 198 | lens fiber cell differentiation (GO:0070306) | 14.8957371 |
| 199 | regulation of skeletal muscle contraction (GO:0014819) | 10.0339551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.62184805 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.03267935 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.52674708 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.08175549 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.94300432 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.51113549 |
| 7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.28303908 |
| 8 | P68_20966046_ChIP-Seq_HELA_Human | 3.23050401 |
| 9 | XRN2_22483619_ChIP-Seq_HELA_Human | 3.06364593 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 3.05867174 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05716871 |
| 12 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 3.00853662 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98956274 |
| 14 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.86625530 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.69410660 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.68909373 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68867117 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62739103 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.61913672 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.61182189 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56992152 |
| 22 | * MAF_26560356_Chip-Seq_TH2_Human | 2.53821261 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.52627523 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.46744916 |
| 25 | * E2F1_20622854_ChIP-Seq_HELA_Human | 2.45539200 |
| 26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.41490380 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38789446 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38789446 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.37292270 |
| 30 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.34981079 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.34961516 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.32334377 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29675534 |
| 34 | * BCOR_27268052_Chip-Seq_Bcells_Human | 2.28760728 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.27329389 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25677135 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.23438839 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.23136047 |
| 39 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.18727084 |
| 40 | * PHF8_20622854_ChIP-Seq_HELA_Human | 2.17156348 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14936004 |
| 42 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.10396367 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 2.09985018 |
| 44 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 2.08977250 |
| 45 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 2.06118364 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.04332985 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.03497367 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 2.03193557 |
| 49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 2.01110142 |
| 50 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.98715524 |
| 51 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.95302069 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93366171 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.92703685 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89849729 |
| 55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85545392 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.85069512 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.84011237 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.83438518 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83427353 |
| 60 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.82264748 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.79620476 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77916744 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75810991 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75485134 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73700671 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72681313 |
| 67 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.72163441 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.68718203 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.68444934 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68251279 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68075559 |
| 72 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67505780 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65889550 |
| 74 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.65433095 |
| 75 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65192608 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64743980 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.62850561 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.62786453 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60201151 |
| 80 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.59138929 |
| 81 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.58934125 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 1.58771074 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57325020 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56083688 |
| 85 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.54536588 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54418926 |
| 87 | ERA_21632823_ChIP-Seq_H3396_Human | 1.51706526 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49307792 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.48803917 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.47850299 |
| 91 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.46149510 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44170701 |
| 93 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.42664634 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.42096742 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39985776 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39371477 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38418231 |
| 98 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.38263904 |
| 99 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34267334 |
| 100 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.34242280 |
| 101 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.33392305 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33357299 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32728463 |
| 104 | * FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.32322813 |
| 105 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.28476568 |
| 106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.27864992 |
| 107 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27833481 |
| 108 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.27476674 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27336500 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26775162 |
| 111 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26459195 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25955159 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25286913 |
| 114 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.24390189 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24332295 |
| 116 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24141372 |
| 117 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.24102148 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22747351 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22561461 |
| 120 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22410906 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22162666 |
| 122 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22047356 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21853365 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20522488 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.19514232 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.19150831 |
| 127 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.18987921 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18959111 |
| 129 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18949402 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.18738517 |
| 131 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.18094075 |
| 132 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17980907 |
| 133 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.17630600 |
| 134 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17537370 |
| 135 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17473588 |
| 136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17200410 |
| 137 | P300_27268052_Chip-Seq_Bcells_Human | 1.15891372 |
| 138 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14468418 |
| 139 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.13952475 |
| 140 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13831896 |
| 141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13643905 |
| 142 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12934597 |
| 143 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12207732 |
| 144 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10286058 |
| 145 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09945983 |
| 146 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.09409730 |
| 147 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09054467 |
| 148 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08505163 |
| 149 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08142140 |
| 150 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07966630 |
| 151 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.07455614 |
| 152 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07410700 |
| 153 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07155900 |
| 154 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06642316 |
| 155 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06631741 |
| 156 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06629356 |
| 157 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06253146 |
| 158 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05228673 |
| 159 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04771075 |
| 160 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04489704 |
| 161 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03667491 |
| 162 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.03579518 |
| 163 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.03577894 |
| 164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02257784 |
| 165 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01490108 |
| 166 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01308461 |
| 167 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01276102 |
| 168 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00840123 |
| 169 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.99390963 |
| 170 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98058648 |
| 171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97951864 |
| 172 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97623782 |
| 173 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96364939 |
| 174 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94465734 |
| 175 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94009088 |
| 176 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93860445 |
| 177 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93489633 |
| 178 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93283679 |
| 179 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91412935 |
| 180 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90926807 |
| 181 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.88365047 |
| 182 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87949645 |
| 183 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87607119 |
| 184 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86301489 |
| 185 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84294233 |
| 186 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.83918435 |
| 187 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83581715 |
| 188 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82683003 |
| 189 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82420635 |
| 190 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81941498 |
| 191 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81740085 |
| 192 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.81714804 |
| 193 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81530213 |
| 194 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81002707 |
| 195 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79966135 |
| 196 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79257577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005193_abnormal_anterior_eye | 6.51515054 |
| 2 | MP0001986_abnormal_taste_sensitivity | 6.45681796 |
| 3 | MP0005423_abnormal_somatic_nervous | 5.93993716 |
| 4 | MP0005253_abnormal_eye_physiology | 4.08739262 |
| 5 | MP0003136_yellow_coat_color | 3.95306278 |
| 6 | MP0006292_abnormal_olfactory_placode | 3.90788530 |
| 7 | MP0005083_abnormal_biliary_tract | 3.17372450 |
| 8 | MP0001286_abnormal_eye_development | 2.95787111 |
| 9 | MP0005197_abnormal_uvea_morphology | 2.87420329 |
| 10 | MP0003880_abnormal_central_pattern | 2.81640886 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.78240837 |
| 12 | MP0003941_abnormal_skin_development | 2.68227534 |
| 13 | MP0002092_abnormal_eye_morphology | 2.63908563 |
| 14 | MP0000749_muscle_degeneration | 2.62155324 |
| 15 | MP0005391_vision/eye_phenotype | 2.53742702 |
| 16 | MP0000751_myopathy | 2.53110911 |
| 17 | MP0001756_abnormal_urination | 2.49146214 |
| 18 | MP0002638_abnormal_pupillary_reflex | 2.29280887 |
| 19 | MP0001661_extended_life_span | 2.20513974 |
| 20 | MP0005171_absent_coat_pigmentation | 2.20215041 |
| 21 | MP0001905_abnormal_dopamine_level | 2.18789814 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 2.09136023 |
| 23 | MP0002160_abnormal_reproductive_system | 2.02272788 |
| 24 | MP0002697_abnormal_eye_size | 10.2131947 |
| 25 | MP0002736_abnormal_nociception_after | 1.90453442 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.86933826 |
| 27 | MP0001346_abnormal_lacrimal_gland | 1.85488823 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.78279780 |
| 29 | MP0004381_abnormal_hair_follicle | 1.77548598 |
| 30 | MP0009379_abnormal_foot_pigmentation | 1.73026502 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.71571497 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.70982586 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.69874858 |
| 34 | MP0002090_abnormal_vision | 1.64441476 |
| 35 | MP0004130_abnormal_muscle_cell | 1.60404664 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.59842304 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.55210320 |
| 38 | MP0004142_abnormal_muscle_tone | 1.54269597 |
| 39 | MP0009745_abnormal_behavioral_response | 1.46988323 |
| 40 | MP0002064_seizures | 1.44809077 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.39756295 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.39331356 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.37026189 |
| 44 | MP0000049_abnormal_middle_ear | 1.36608522 |
| 45 | MP0005332_abnormal_amino_acid | 1.36172257 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.31197426 |
| 47 | MP0004270_analgesia | 1.29040465 |
| 48 | MP0002272_abnormal_nervous_system | 1.28418564 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.27983409 |
| 50 | MP0005365_abnormal_bile_salt | 1.27809962 |
| 51 | MP0002234_abnormal_pharynx_morphology | 1.27566335 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.27148466 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.26450984 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.23770496 |
| 55 | MP0001486_abnormal_startle_reflex | 1.21876019 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.20400267 |
| 57 | MP0005501_abnormal_skin_physiology | 1.18375081 |
| 58 | MP0005410_abnormal_fertilization | 1.18291031 |
| 59 | MP0000747_muscle_weakness | 1.17705587 |
| 60 | MP0000778_abnormal_nervous_system | 1.17325779 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.16220418 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.15127103 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.11920895 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.11910403 |
| 65 | MP0001919_abnormal_reproductive_system | 1.09362322 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.07678988 |
| 67 | MP0005409_darkened_coat_color | 1.07514769 |
| 68 | MP0005195_abnormal_posterior_eye | 1.06764528 |
| 69 | MP0002177_abnormal_outer_ear | 1.04423297 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.04419868 |
| 71 | MP0003879_abnormal_hair_cell | 1.03662773 |
| 72 | MP0000470_abnormal_stomach_morphology | 0.98764353 |
| 73 | MP0004272_abnormal_basement_membrane | 0.97171450 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.96958306 |
| 75 | MP0009046_muscle_twitch | 0.96147853 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.96004964 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.95285198 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94970055 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.94343552 |
| 80 | MP0002557_abnormal_social/conspecific_i | 0.92474708 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 0.91702851 |
| 82 | MP0001188_hyperpigmentation | 0.91474261 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.91008819 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.90577106 |
| 85 | MP0000920_abnormal_myelination | 0.88752560 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.86502849 |
| 87 | MP0003878_abnormal_ear_physiology | 0.86502849 |
| 88 | MP0002184_abnormal_innervation | 0.86332257 |
| 89 | MP0004858_abnormal_nervous_system | 0.86153903 |
| 90 | MP0008260_abnormal_autophagy | 0.84380743 |
| 91 | MP0005389_reproductive_system_phenotype | 0.82967802 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.82439908 |
| 93 | MP0001529_abnormal_vocalization | 0.82236843 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.81133110 |
| 95 | MP0001873_stomach_inflammation | 0.80127030 |
| 96 | MP0004133_heterotaxia | 0.78505605 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.78082323 |
| 98 | MP0001970_abnormal_pain_threshold | 0.76872858 |
| 99 | MP0002882_abnormal_neuron_morphology | 0.76849001 |
| 100 | MP0002163_abnormal_gland_morphology | 0.75972491 |
| 101 | MP0004957_abnormal_blastocyst_morpholog | 0.75913091 |
| 102 | MP0001958_emphysema | 0.74575303 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.73923816 |
| 104 | MP0003077_abnormal_cell_cycle | 0.73396563 |
| 105 | MP0001440_abnormal_grooming_behavior | 0.72035941 |
| 106 | MP0000367_abnormal_coat/_hair | 0.70585713 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.70057227 |
| 108 | MP0002254_reproductive_system_inflammat | 0.69820937 |
| 109 | MP0001340_abnormal_eyelid_morphology | 0.69693837 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.68630053 |
| 111 | MP0005646_abnormal_pituitary_gland | 0.68462330 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.68071294 |
| 113 | MP0004742_abnormal_vestibular_system | 0.68059821 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.68027080 |
| 115 | MP0008569_lethality_at_weaning | 0.67553251 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.67526638 |
| 117 | MP0003938_abnormal_ear_development | 0.67207766 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.66975564 |
| 119 | MP0004215_abnormal_myocardial_fiber | 0.66604199 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.66255671 |
| 121 | MP0000026_abnormal_inner_ear | 0.65677039 |
| 122 | MP0000358_abnormal_cell_content/ | 0.64557136 |
| 123 | MP0009931_abnormal_skin_appearance | 0.64019029 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.62970274 |
| 125 | MP0003123_paternal_imprinting | 0.62042532 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.61975036 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.61853791 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.61648514 |
| 129 | MP0002928_abnormal_bile_duct | 0.60549124 |
| 130 | MP0001324_abnormal_eye_pigmentation | 0.59862505 |
| 131 | MP0002249_abnormal_larynx_morphology | 0.59010384 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.57533708 |
| 133 | MP0010771_integument_phenotype | 0.57264098 |
| 134 | MP0004924_abnormal_behavior | 0.56927886 |
| 135 | MP0005386_behavior/neurological_phenoty | 0.56927886 |
| 136 | MP0004147_increased_porphyrin_level | 0.56756177 |
| 137 | MP0000955_abnormal_spinal_cord | 0.56752714 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.56411983 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.56362374 |
| 140 | MP0002152_abnormal_brain_morphology | 0.56087817 |
| 141 | MP0004197_abnormal_fetal_growth/weight/ | 0.54846134 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.54592921 |
| 143 | MP0004043_abnormal_pH_regulation | 0.54372398 |
| 144 | MP0002938_white_spotting | 0.54054965 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.53582651 |
| 146 | MP0003122_maternal_imprinting | 0.53483569 |
| 147 | MP0003448_altered_tumor_morphology | 0.52374067 |
| 148 | MP0004885_abnormal_endolymph | 0.52131476 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.51144122 |
| 150 | MP0002210_abnormal_sex_determination | 0.50746925 |
| 151 | MP0005330_cardiomyopathy | 0.49828165 |
| 152 | MP0002876_abnormal_thyroid_physiology | 0.49820650 |
| 153 | MP0010094_abnormal_chromosome_stability | 0.49689278 |
| 154 | MP0008770_decreased_survivor_rate | 0.49623485 |
| 155 | MP0002229_neurodegeneration | 0.49585590 |
| 156 | MP0003303_peritoneal_inflammation | 0.48059595 |
| 157 | MP0002751_abnormal_autonomic_nervous | 0.47868717 |
| 158 | MP0001765_abnormal_ion_homeostasis | 0.47290770 |
| 159 | MP0001664_abnormal_digestion | 0.47123343 |
| 160 | MP0001191_abnormal_skin_condition | 0.47001266 |
| 161 | MP0003315_abnormal_perineum_morphology | 0.44348738 |
| 162 | MP0003011_delayed_dark_adaptation | 0.43816582 |
| 163 | MP0005085_abnormal_gallbladder_physiolo | 0.42598931 |
| 164 | MP0002075_abnormal_coat/hair_pigmentati | 0.40976885 |
| 165 | MP0005375_adipose_tissue_phenotype | 0.40671753 |
| 166 | MP0002118_abnormal_lipid_homeostasis | 0.40629419 |
| 167 | MP0009840_abnormal_foam_cell | 0.36893308 |
| 168 | MP0004087_abnormal_muscle_fiber | 0.36405812 |
| 169 | MP0003632_abnormal_nervous_system | 0.35760595 |
| 170 | MP0003091_abnormal_cell_migration | 0.33460177 |
| 171 | MP0009384_cardiac_valve_regurgitation | 0.32402292 |
| 172 | MP0001784_abnormal_fluid_regulation | 0.32069239 |
| 173 | MP0003943_abnormal_hepatobiliary_system | 0.31255886 |
| 174 | MP0010769_abnormal_survival | 0.31185801 |
| 175 | MP0002933_joint_inflammation | 0.31072991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital cataract (HP:0000519) | 7.22882308 |
| 2 | Corneal dystrophy (HP:0001131) | 7.13577586 |
| 3 | Testicular atrophy (HP:0000029) | 6.84778149 |
| 4 | Amblyopia (HP:0000646) | 6.78555137 |
| 5 | Anterior segment dysgenesis (HP:0007700) | 5.90522075 |
| 6 | Dyschromatopsia (HP:0007641) | 5.80575015 |
| 7 | Rectovaginal fistula (HP:0000143) | 5.48873788 |
| 8 | Rectal fistula (HP:0100590) | 5.48873788 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 5.48201300 |
| 10 | Intestinal fistula (HP:0100819) | 5.13691954 |
| 11 | Poikiloderma (HP:0001029) | 5.07325104 |
| 12 | Vaginal fistula (HP:0004320) | 4.97633783 |
| 13 | Thin bony cortex (HP:0002753) | 4.94055359 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.67773182 |
| 15 | Facial hemangioma (HP:0000329) | 4.64497826 |
| 16 | Annular pancreas (HP:0001734) | 4.57557726 |
| 17 | Mesangial abnormality (HP:0001966) | 4.40759682 |
| 18 | Congenital stationary night blindness (HP:0007642) | 4.31955601 |
| 19 | Facial diplegia (HP:0001349) | 4.30632895 |
| 20 | Ulnar bowing (HP:0003031) | 4.20902412 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 4.18199479 |
| 22 | Joint hemorrhage (HP:0005261) | 4.10426597 |
| 23 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.05721850 |
| 24 | Turricephaly (HP:0000262) | 4.03553990 |
| 25 | Clumsiness (HP:0002312) | 4.01086189 |
| 26 | Polar cataract (HP:0010696) | 3.95642408 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.93799598 |
| 28 | Coronal craniosynostosis (HP:0004440) | 3.80881957 |
| 29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.80722813 |
| 30 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.79801013 |
| 31 | Increased hepatocellular lipid droplets (HP:0006565) | 3.77181057 |
| 32 | Choroideremia (HP:0001139) | 3.72439866 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 3.65163655 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 3.58343607 |
| 35 | Squamous cell carcinoma (HP:0002860) | 3.54794857 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 3.54316471 |
| 37 | Microcornea (HP:0000482) | 3.52965824 |
| 38 | Anteriorly placed anus (HP:0001545) | 3.52469550 |
| 39 | Chorioretinal atrophy (HP:0000533) | 3.45906193 |
| 40 | Patellar aplasia (HP:0006443) | 3.39730319 |
| 41 | Short chin (HP:0000331) | 3.26780874 |
| 42 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.22337182 |
| 43 | Hypoalbuminemia (HP:0003073) | 3.17931905 |
| 44 | Abnormal albumin level (HP:0012116) | 3.17931905 |
| 45 | Decreased central vision (HP:0007663) | 3.13317124 |
| 46 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.12697434 |
| 47 | Atrioventricular block (HP:0001678) | 3.11000108 |
| 48 | Iris coloboma (HP:0000612) | 3.05535109 |
| 49 | Enlarged epiphyses (HP:0010580) | 3.01133027 |
| 50 | Abnormality of the costochondral junction (HP:0000919) | 3.00024175 |
| 51 | Nuclear cataract (HP:0100018) | 25.9052232 |
| 52 | Zonular cataract (HP:0010920) | 22.9777796 |
| 53 | Myotonia (HP:0002486) | 2.97857072 |
| 54 | Eosinophilia (HP:0001880) | 2.97772839 |
| 55 | Hypophosphatemic rickets (HP:0004912) | 2.94004958 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.79723426 |
| 57 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.77024660 |
| 58 | Absent thumb (HP:0009777) | 2.76254621 |
| 59 | Capillary hemangiomas (HP:0005306) | 2.74930836 |
| 60 | Sclerocornea (HP:0000647) | 2.64123820 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.62895946 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54531319 |
| 63 | Neonatal onset (HP:0003623) | 2.50102301 |
| 64 | Opacification of the corneal stroma (HP:0007759) | 2.49700072 |
| 65 | Premature graying of hair (HP:0002216) | 2.49173793 |
| 66 | Widely patent fontanelles and sutures (HP:0004492) | 2.48725081 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.42001859 |
| 68 | Bowing of the arm (HP:0006488) | 2.41728985 |
| 69 | Bowed forearm bones (HP:0003956) | 2.41728985 |
| 70 | Joint stiffness (HP:0001387) | 2.39688410 |
| 71 | Granulocytopenia (HP:0001913) | 2.39656845 |
| 72 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.38797420 |
| 73 | Choanal stenosis (HP:0000452) | 2.38030667 |
| 74 | Abnormality of the anterior chamber (HP:0000593) | 2.36953481 |
| 75 | Abnormal epiphyseal ossification (HP:0010656) | 2.35234530 |
| 76 | Narrow nasal bridge (HP:0000446) | 2.33538788 |
| 77 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31724968 |
| 78 | Exertional dyspnea (HP:0002875) | 2.31577216 |
| 79 | Flat occiput (HP:0005469) | 2.29534426 |
| 80 | Short humerus (HP:0005792) | 2.26884279 |
| 81 | Increased number of teeth (HP:0011069) | 2.26410105 |
| 82 | Abnormal urine phosphate concentration (HP:0012599) | 2.25463155 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.22292111 |
| 84 | Male infertility (HP:0003251) | 2.21596540 |
| 85 | Respiratory difficulties (HP:0002880) | 2.15195349 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.13486743 |
| 87 | Basal cell carcinoma (HP:0002671) | 2.10836804 |
| 88 | Type 2 muscle fiber atrophy (HP:0003554) | 2.06433133 |
| 89 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.03294003 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.03259865 |
| 91 | Epiphyseal stippling (HP:0010655) | 2.01126064 |
| 92 | Pterygium (HP:0001059) | 2.00031520 |
| 93 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.99946769 |
| 94 | Abnormal drinking behavior (HP:0030082) | 1.97065184 |
| 95 | Polydipsia (HP:0001959) | 1.97065184 |
| 96 | Myopathic facies (HP:0002058) | 1.96807694 |
| 97 | Cystic hygroma (HP:0000476) | 1.94745818 |
| 98 | Absent radius (HP:0003974) | 1.94268466 |
| 99 | Fetal akinesia sequence (HP:0001989) | 1.91289324 |
| 100 | Muscle fiber atrophy (HP:0100295) | 1.91289050 |
| 101 | Fatigable weakness (HP:0003473) | 1.91159602 |
| 102 | Abnormality of the neuromuscular junction (HP:0003398) | 1.91159602 |
| 103 | Akinesia (HP:0002304) | 1.90628783 |
| 104 | Hypoplasia of the radius (HP:0002984) | 1.89944869 |
| 105 | Abnormality of the hepatic vasculature (HP:0006707) | 1.88264432 |
| 106 | Heart block (HP:0012722) | 1.88205251 |
| 107 | Cheilitis (HP:0100825) | 1.86981274 |
| 108 | Proximal amyotrophy (HP:0007126) | 1.82121432 |
| 109 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.80744159 |
| 110 | Aplasia of the musculature (HP:0100854) | 1.79622337 |
| 111 | Neonatal respiratory distress (HP:0002643) | 1.75587446 |
| 112 | Hypoplastic nipples (HP:0002557) | 1.74156498 |
| 113 | Focal motor seizures (HP:0011153) | 1.73214130 |
| 114 | Amniotic constriction ring (HP:0009775) | 1.72305465 |
| 115 | Abnormality of placental membranes (HP:0011409) | 1.72305465 |
| 116 | Scapular winging (HP:0003691) | 1.53533582 |
| 117 | Hypoplastic heart (HP:0001961) | 1.48001510 |
| 118 | Severe visual impairment (HP:0001141) | 1.47440623 |
| 119 | Posterior subcapsular cataract (HP:0007787) | 1.39464510 |
| 120 | Popliteal pterygium (HP:0009756) | 1.38916661 |
| 121 | Leukocytosis (HP:0001974) | 1.37197971 |
| 122 | Split foot (HP:0001839) | 1.35753355 |
| 123 | Hypothermia (HP:0002045) | 1.29127820 |
| 124 | Rib fusion (HP:0000902) | 1.20108600 |
| 125 | Difficulty walking (HP:0002355) | 1.08805208 |
| 126 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.08085500 |
| 127 | Long clavicles (HP:0000890) | 1.03742322 |
| 128 | Chorioretinal coloboma (HP:0000567) | 1.02605968 |
| 129 | Hypoplasia of the fovea (HP:0007750) | 1.02418856 |
| 130 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.02418856 |
| 131 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.00319388 |
| 132 | Blue irides (HP:0000635) | 0.99010779 |
| 133 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 0.98765122 |
| 134 | Retinal dysplasia (HP:0007973) | 0.97756552 |
| 135 | Atelectasis (HP:0100750) | 0.96977489 |
| 136 | Decreased circulating renin level (HP:0003351) | 0.96885507 |
| 137 | Abnormality of the shoulder girdle musculature (HP:0001435) | 0.96232356 |
| 138 | Diminished movement (HP:0002374) | 0.95105150 |
| 139 | Myelomeningocele (HP:0002475) | 0.94637923 |
| 140 | Neoplasm of the heart (HP:0100544) | 0.91751383 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 0.91480463 |
| 142 | Abnormal number of incisors (HP:0011064) | 0.91421342 |
| 143 | Malignant hyperthermia (HP:0002047) | 0.91071436 |
| 144 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 0.88739136 |
| 145 | Broad-based gait (HP:0002136) | 0.85421504 |
| 146 | Epileptic encephalopathy (HP:0200134) | 0.84519665 |
| 147 | Abnormality of the fovea (HP:0000493) | 0.84231778 |
| 148 | Microvesicular hepatic steatosis (HP:0001414) | 0.82568908 |
| 149 | Meningocele (HP:0002435) | 0.82555836 |
| 150 | Prolonged QT interval (HP:0001657) | 0.79998351 |
| 151 | Morphological abnormality of the inner ear (HP:0011390) | 0.79359498 |
| 152 | Humeroradial synostosis (HP:0003041) | 0.79237768 |
| 153 | Synostosis involving the elbow (HP:0003938) | 0.79237768 |
| 154 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 0.78888882 |
| 155 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 0.78888882 |
| 156 | Abnormality of cochlea (HP:0000375) | 0.78707487 |
| 157 | Hyperventilation (HP:0002883) | 0.77105377 |
| 158 | Hemiparesis (HP:0001269) | 0.76318563 |
| 159 | Spastic gait (HP:0002064) | 0.76003177 |
| 160 | Fused cervical vertebrae (HP:0002949) | 0.73793162 |
| 161 | Submucous cleft hard palate (HP:0000176) | 0.72688408 |
| 162 | Type II lissencephaly (HP:0007260) | 0.72590370 |
| 163 | Limb dystonia (HP:0002451) | 0.72256957 |
| 164 | Nonprogressive disorder (HP:0003680) | 0.71983568 |
| 165 | Lymphangioma (HP:0100764) | 0.71797002 |
| 166 | Protruding tongue (HP:0010808) | 0.70616506 |
| 167 | Febrile seizures (HP:0002373) | 0.69146997 |
| 168 | Hepatocellular necrosis (HP:0001404) | 0.68737559 |
| 169 | Focal seizures (HP:0007359) | 0.68600258 |
| 170 | Hypoplastic pelvis (HP:0008839) | 0.68327751 |
| 171 | Supranuclear gaze palsy (HP:0000605) | 0.68112254 |
| 172 | Optic nerve hypoplasia (HP:0000609) | 0.67796327 |
| 173 | Hypoparathyroidism (HP:0000829) | 0.66235961 |
| 174 | Abnormality of dental color (HP:0011073) | 0.66129855 |
| 175 | Aplasia cutis congenita (HP:0001057) | 0.65633143 |
| 176 | Poor head control (HP:0002421) | 0.64979880 |
| 177 | Hypoplastic left heart (HP:0004383) | 0.64841219 |
| 178 | Vertebral clefting (HP:0008428) | 0.63059768 |
| 179 | Psychosis (HP:0000709) | 0.62902052 |
| 180 | Hyperkalemia (HP:0002153) | 0.62687692 |
| 181 | Poor suck (HP:0002033) | 0.62521346 |
| 182 | Sensory axonal neuropathy (HP:0003390) | 0.61968500 |
| 183 | Hyperactive renin-angiotensin system (HP:0000841) | 0.61960477 |
| 184 | Thin ribs (HP:0000883) | 0.61844689 |
| 185 | Progressive cerebellar ataxia (HP:0002073) | 0.61796379 |
| 186 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 0.61447431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.63694588 |
| 2 | INSRR | 4.97614768 |
| 3 | MAP2K6 | 4.31652504 |
| 4 | NTRK3 | 3.91712084 |
| 5 | BLK | 3.01609462 |
| 6 | STK39 | 2.55181328 |
| 7 | WNK4 | 2.26678987 |
| 8 | TESK2 | 2.25535435 |
| 9 | MAPK13 | 2.18185196 |
| 10 | CASK | 2.03899310 |
| 11 | MAPK15 | 10.7327929 |
| 12 | SGK1 | 1.97210188 |
| 13 | MAP2K7 | 1.91906454 |
| 14 | GRK6 | 1.86929874 |
| 15 | MAP3K12 | 1.79987778 |
| 16 | SIK2 | 1.79769064 |
| 17 | PRPF4B | 1.73297822 |
| 18 | ACVR1B | 1.69534637 |
| 19 | FLT3 | 1.69172071 |
| 20 | PKN1 | 1.63349629 |
| 21 | ZAK | 1.61489080 |
| 22 | PRKD2 | 1.60460858 |
| 23 | SIK1 | 1.57339144 |
| 24 | IRAK4 | 1.54433909 |
| 25 | AKT3 | 1.52742029 |
| 26 | FES | 1.51593033 |
| 27 | TRIB3 | 1.50200715 |
| 28 | CDK19 | 1.47864172 |
| 29 | PRKG1 | 1.36800002 |
| 30 | ERN1 | 1.30856384 |
| 31 | CCNB1 | 1.30179257 |
| 32 | DYRK2 | 1.29372387 |
| 33 | SCYL2 | 1.28679967 |
| 34 | BMPR1B | 1.26239831 |
| 35 | IRAK2 | 1.23983861 |
| 36 | PDPK1 | 1.20196675 |
| 37 | EIF2AK3 | 1.17810545 |
| 38 | MUSK | 1.14971553 |
| 39 | STK10 | 1.09489186 |
| 40 | PRKD3 | 1.06642687 |
| 41 | MARK3 | 1.06478407 |
| 42 | ZAP70 | 1.06235106 |
| 43 | DAPK2 | 1.03315241 |
| 44 | MAP2K3 | 0.99543320 |
| 45 | CDK6 | 0.98404447 |
| 46 | WNK1 | 0.93178458 |
| 47 | CDK15 | 0.91886191 |
| 48 | YES1 | 0.90373375 |
| 49 | PRKD1 | 0.90004087 |
| 50 | RIPK4 | 0.89740496 |
| 51 | PDK2 | 0.89570509 |
| 52 | CDK11A | 0.89302298 |
| 53 | BMX | 0.88337208 |
| 54 | FGR | 0.87004899 |
| 55 | IRAK1 | 0.85870881 |
| 56 | NEK2 | 0.85715931 |
| 57 | CDK18 | 0.84856137 |
| 58 | CSK | 0.83768246 |
| 59 | TRIM28 | 0.83500925 |
| 60 | EIF2AK2 | 0.81315716 |
| 61 | CDK8 | 0.80873243 |
| 62 | ERBB2 | 0.80482418 |
| 63 | CDK4 | 0.79703837 |
| 64 | MARK1 | 0.79126515 |
| 65 | RPS6KA6 | 0.78711313 |
| 66 | STK16 | 0.78402978 |
| 67 | MKNK2 | 0.77898407 |
| 68 | CAMK1D | 0.77729301 |
| 69 | EPHA4 | 0.76935855 |
| 70 | PIM2 | 0.74809089 |
| 71 | IGF1R | 0.72103638 |
| 72 | ADRBK1 | 0.71665461 |
| 73 | EPHB2 | 0.68650738 |
| 74 | MAPKAPK5 | 0.68644038 |
| 75 | KIT | 0.67499607 |
| 76 | PRKACB | 0.67021871 |
| 77 | UHMK1 | 0.66785727 |
| 78 | INSR | 0.66732320 |
| 79 | PRKCQ | 0.64870397 |
| 80 | PRKCB | 0.64214603 |
| 81 | PRKCE | 0.63608839 |
| 82 | CAMK1 | 0.63117529 |
| 83 | MST4 | 0.62250624 |
| 84 | AURKA | 0.61054309 |
| 85 | MARK2 | 0.60715280 |
| 86 | CSF1R | 0.60411158 |
| 87 | CSNK1G2 | 0.60153213 |
| 88 | PINK1 | 0.59905307 |
| 89 | OXSR1 | 0.59837635 |
| 90 | ROCK2 | 0.57587605 |
| 91 | TBK1 | 0.57327928 |
| 92 | CSNK1D | 0.57202516 |
| 93 | TLK1 | 0.56530847 |
| 94 | ARAF | 0.55477564 |
| 95 | LIMK1 | 0.55449841 |
| 96 | MTOR | 0.54755270 |
| 97 | PHKG1 | 0.54592562 |
| 98 | PHKG2 | 0.54592562 |
| 99 | BCKDK | 0.54347117 |
| 100 | STK11 | 0.54336584 |
| 101 | CDK14 | 0.54267605 |
| 102 | NLK | 0.53711518 |
| 103 | MAPK11 | 0.52512973 |
| 104 | RPS6KA5 | 0.52357625 |
| 105 | ATR | 0.52024970 |
| 106 | MAP2K4 | 0.51658616 |
| 107 | KSR1 | 0.51653971 |
| 108 | MAP3K7 | 0.50857253 |
| 109 | PAK1 | 0.49796178 |
| 110 | MAPK8 | 0.49790653 |
| 111 | DAPK1 | 0.48636030 |
| 112 | NTRK1 | 0.47855713 |
| 113 | RPS6KA3 | 0.47300804 |
| 114 | JAK3 | 0.46988909 |
| 115 | CAMK2B | 0.46921973 |
| 116 | TGFBR1 | 0.46519485 |
| 117 | MST1R | 0.46022451 |
| 118 | MKNK1 | 0.43917771 |
| 119 | NEK6 | 0.43845443 |
| 120 | ICK | 0.42854053 |
| 121 | CHEK2 | 0.42801912 |
| 122 | CDK5 | 0.42700695 |
| 123 | DYRK1B | 0.42495987 |
| 124 | SGK223 | 0.42398393 |
| 125 | SGK494 | 0.42398393 |
| 126 | PRKAA1 | 0.41805481 |
| 127 | ADRBK2 | 0.40594317 |
| 128 | CAMK2A | 0.40580280 |
| 129 | CAMK1G | 0.40118683 |
| 130 | MAPK10 | 0.39754787 |
| 131 | MAP3K4 | 0.39218791 |
| 132 | HIPK2 | 0.39175663 |
| 133 | GRK1 | 0.39090490 |
| 134 | EEF2K | 0.38582686 |
| 135 | EPHB1 | 0.38189040 |
| 136 | TAOK2 | 0.37611413 |
| 137 | PRKCG | 0.37049626 |
| 138 | MAPK12 | 0.35778044 |
| 139 | MAP3K9 | 0.35580312 |
| 140 | RPS6KA2 | 0.34540653 |
| 141 | RPS6KC1 | 0.34372097 |
| 142 | RPS6KL1 | 0.34372097 |
| 143 | PRKCH | 0.33620292 |
| 144 | MELK | 0.33530055 |
| 145 | PLK1 | 0.33414990 |
| 146 | IKBKB | 0.32187946 |
| 147 | CDC42BPA | 0.29483510 |
| 148 | MINK1 | 0.28885854 |
| 149 | DYRK1A | 0.28880994 |
| 150 | PRKCD | 0.28303028 |
| 151 | PRKACA | 0.28265660 |
| 152 | STK38 | 0.28264109 |
| 153 | PRKCI | 0.28005452 |
| 154 | DYRK3 | 0.25728128 |
| 155 | CSNK1G3 | 0.25516116 |
| 156 | CAMK2G | 0.25295418 |
| 157 | IKBKE | 0.24847617 |
| 158 | CDK1 | 0.24376424 |
| 159 | BMPR2 | 0.24247224 |
| 160 | BRAF | 0.21891805 |
| 161 | SGK3 | 0.20954875 |
| 162 | EPHA2 | 0.19811948 |
| 163 | MAP2K1 | 0.19456193 |
| 164 | CAMKK2 | 0.17700476 |
| 165 | GSK3B | 0.17442179 |
| 166 | CDK2 | 0.16986403 |
| 167 | MAPK3 | 0.16614933 |
| 168 | AKT1 | 0.16036546 |
| 169 | TIE1 | 0.14965216 |
| 170 | LYN | 0.14023153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 6.83509108 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.54345626 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.01530129 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.86653979 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.85691243 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.68336231 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.63912043 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62147863 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58450164 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.45919628 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.18999447 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.15087103 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.14458274 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.13955337 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12641697 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11369752 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.08525492 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01072148 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.83464497 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.83273409 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.79510531 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79497978 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.69265080 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.69120575 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61328394 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60054428 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59297674 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55938079 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.55457622 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51043950 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.50781005 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50231039 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48554708 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.45779556 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45213574 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.44367953 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42705863 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41312828 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.40775549 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.38705095 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.33334308 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32140164 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28516696 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.27880505 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27647641 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25807880 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20185219 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.14877250 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.06758832 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04570496 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04195000 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03887754 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02192086 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02072945 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01007649 |
| 56 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.97519948 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94650152 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94198840 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93671473 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91966416 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89145109 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88421984 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.85270140 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80675308 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79988318 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79654812 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79594872 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79537009 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78677896 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77877109 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74211683 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72967273 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72579372 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69275959 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68102500 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66647551 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66532585 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.65529645 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64678507 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63841090 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63523173 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63327359 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.62816288 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61397080 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.60114417 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60021481 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58222109 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57715855 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.54999393 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53726231 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52833156 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52199206 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50885808 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.50691174 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50414595 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49992958 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49514066 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48512133 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48181006 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.46184887 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.45186072 |
| 102 | Homologous recombination_Homo sapiens_hsa03440 | 0.45121788 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44341853 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44049111 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43801234 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42958489 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42918728 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42013987 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41982442 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40150394 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39667412 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.38989470 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.38635874 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.38471529 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.36984966 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36611925 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36134090 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35450202 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35081243 |
| 120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34329117 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32662338 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.32068001 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.31754454 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.31332759 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30284262 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30241082 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.30198531 |
| 128 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29136439 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.28824038 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.27447121 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27413986 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27104911 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27087654 |
| 134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27028843 |
| 135 | ABC transporters_Homo sapiens_hsa02010 | 0.26902600 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.24815851 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24570058 |
| 138 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.24552663 |
| 139 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.23753149 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23629615 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23445856 |
| 142 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.23263246 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22955127 |
| 144 | Bile secretion_Homo sapiens_hsa04976 | 0.21667440 |
| 145 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21576460 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19962071 |
| 147 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19116545 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.18675572 |
| 149 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.17577551 |
| 150 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16922198 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.16879573 |
| 152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.16720916 |
| 153 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.13694771 |
| 154 | Peroxisome_Homo sapiens_hsa04146 | 0.12915569 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12616694 |
| 156 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.11910302 |
| 157 | Cell cycle_Homo sapiens_hsa04110 | 0.11072789 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08820472 |
| 159 | Histidine metabolism_Homo sapiens_hsa00340 | 0.08587669 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.07826449 |
| 161 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07471219 |

